These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 1705871)

  • 1. Stable isotope dilution analysis of very long chain fatty acids in plasma, urine and amniotic fluid by electron capture negative ion mass fragmentography.
    Stellaard F; ten Brink HJ; Kok RM; van den Heuvel L; Jakobs C
    Clin Chim Acta; 1990 Nov; 192(2):133-44. PubMed ID: 1705871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pristanic acid and phytanic acid in plasma from patients with peroxisomal disorders: stable isotope dilution analysis with electron capture negative ion mass fragmentography.
    ten Brink HJ; Stellaard F; van den Heuvel CM; Kok RM; Schor DS; Wanders RJ; Jakobs C
    J Lipid Res; 1992 Jan; 33(1):41-7. PubMed ID: 1372637
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ratios for very-long-chain fatty acids in plasma of subjects with peroxisomal disorders, as determined by HPLC and validated by gas chromatography-mass spectrometry.
    Hall NA; Lynes GW; Hjelm NM
    Clin Chem; 1988 Jun; 34(6):1041-5. PubMed ID: 2454167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stable isotope dilution analysis of pipecolic acid in cerebrospinal fluid, plasma, urine and amniotic fluid using electron capture negative ion mass fragmentography.
    Kok RM; Kaster L; de Jong AP; Poll-Thé B; Saudubray JM; Jakobs C
    Clin Chim Acta; 1987 Sep; 168(2):143-52. PubMed ID: 3315316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved determination of very-long-chain fatty acids in plasma and cultured skin fibroblasts: applications to the diagnosis of peroxisomal disorders.
    Onkenhout W; van der Poel PF; van den Heuvel MP
    J Chromatogr; 1989 Sep; 494():31-41. PubMed ID: 2479651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Application of machine learning algorithms for the differential diagnosis of peroxisomal disorders.
    Subhashini P; Jaya Krishna S; Usha Rani G; Sushma Chander N; Maheshwar Reddy G; Naushad SM
    J Biochem; 2019 Jan; 165(1):67-73. PubMed ID: 30295825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pre- and postnatal diagnosis of peroxisomal disorders using stable-isotope dilution gas chromatography--mass spectrometry.
    Verhoeven NM; Kulik W; van den Heuvel CM; Jakobs C
    J Inherit Metab Dis; 1995; 18 Suppl 1():45-60. PubMed ID: 9053555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gas chromatography/mass spectrometry analysis of very long chain fatty acids, docosahexaenoic acid, phytanic acid and plasmalogen for the screening of peroxisomal disorders.
    Takemoto Y; Suzuki Y; Horibe R; Shimozawa N; Wanders RJ; Kondo N
    Brain Dev; 2003 Oct; 25(7):481-7. PubMed ID: 13129591
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Profiles of very-long-chain fatty acids in plasma, fibroblasts, and blood cells in Zellweger syndrome, X-linked adrenoleukodystrophy, and rhizomelic chondrodysplasia punctata.
    Schutgens RB; Bouman IW; Nijenhuis AA; Wanders RJ; Frumau ME
    Clin Chem; 1993 Aug; 39(8):1632-7. PubMed ID: 8353949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Peroxisomal neurologic diseases and Refsum disease: very long chain fatty acids and phytanic acid as diagnostic markers].
    Molzer B; Stöckler S; Bernheimer H
    Wien Klin Wochenschr; 1992; 104(21):665-70. PubMed ID: 1282286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Excretion of 3,6-epoxydicarboxylic acids in peroxisomal disorders.
    Pitt JJ; Poulos A
    Clin Chim Acta; 1993 Dec; 223(1-2):23-9. PubMed ID: 7511488
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma polyenoic very-long-chain fatty acids in peroxisomal disease: biochemical discrimination of Zellweger's syndrome from other phenotypes.
    Poulos A; Sharp P; Johnson D
    Neurology; 1989 Jan; 39(1):44-7. PubMed ID: 2462697
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An improved method for quantification of very long chain fatty acids in plasma.
    Vallance H; Applegarth D
    Clin Biochem; 1994 Jun; 27(3):183-6. PubMed ID: 7522996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid liquid chromatography-tandem mass spectrometry to determine very-long-chain fatty acids in human and to establish reference intervals for the Chinese population.
    Wang D; Yu S; Zhang Y; Yin Y; Cheng Q; Xie S; Yu J; Li H; Cheng X; Qiu L
    Clin Chim Acta; 2019 Aug; 495():185-190. PubMed ID: 30978326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of C26:0-lysophosphatidylcholine and C26:0-carnitine as diagnostic markers for Zellweger spectrum disorders.
    Klouwer FCC; Ferdinandusse S; van Lenthe H; Kulik W; Wanders RJA; Poll-The BT; Waterham HR; Vaz FM
    J Inherit Metab Dis; 2017 Nov; 40(6):875-881. PubMed ID: 28677031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stable isotope dilution analysis of succinylacetone using electron capture negative ion mass fragmentography: an accurate approach to the pre- and neonatal diagnosis of hereditary tyrosinemia type I.
    Jakobs C; Dorland L; Wikkerink B; Kok RM; de Jong AP; Wadman SK
    Clin Chim Acta; 1988 Feb; 171(2-3):223-31. PubMed ID: 3286060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative determination of plasma c8-c26 total fatty acids for the biochemical diagnosis of nutritional and metabolic disorders.
    Lagerstedt SA; Hinrichs DR; Batt SM; Magera MJ; Rinaldo P; McConnell JP
    Mol Genet Metab; 2001 May; 73(1):38-45. PubMed ID: 11350181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Very long-chain fatty acids in peroxisomal disease.
    Poulos A; Beckman K; Johnson DW; Paton BC; Robinson BS; Sharp P; Usher S; Singh H
    Adv Exp Med Biol; 1992; 318():331-40. PubMed ID: 1378993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urine acylcarnitine analysis by ESI-MS/MS: a new tool for the diagnosis of peroxisomal biogenesis disorders.
    Duranti G; Boenzi S; Rizzo C; Ravà L; Di Ciommo V; Carrozzo R; Meschini MC; Johnson DW; Dionisi-Vici C
    Clin Chim Acta; 2008 Dec; 398(1-2):86-9. PubMed ID: 18793625
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and clinical profiles of 52 Tunisian patients affected by Zellweger syndrome.
    Nasrallah F; Zidi W; Feki M; Kacem S; Tebib N; Kaabachi N
    Pediatr Neonatol; 2017 Dec; 58(6):484-489. PubMed ID: 28330580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.